Daniel Eiras

1.8k total citations · 1 hit paper
17 papers, 371 citations indexed

About

Daniel Eiras is a scholar working on Epidemiology, Pharmacology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Daniel Eiras has authored 17 papers receiving a total of 371 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Epidemiology, 4 papers in Pharmacology and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Daniel Eiras's work include Respiratory viral infections research (5 papers), Antibiotics Pharmacokinetics and Efficacy (4 papers) and Epilepsy research and treatment (3 papers). Daniel Eiras is often cited by papers focused on Respiratory viral infections research (5 papers), Antibiotics Pharmacokinetics and Efficacy (4 papers) and Epilepsy research and treatment (3 papers). Daniel Eiras collaborates with scholars based in United States, United Kingdom and Japan. Daniel Eiras's co-authors include E. Yoko Furuya, David P. Calfee, Angela Loo, Christine J. Kubin, Brian Nelson, Laura A. Kirkman, Henry W. Murray, Susan Whittier, Michael J. Satlin and Angela Gomez‐Simmonds and has published in prestigious journals such as Clinical Infectious Diseases, Antimicrobial Agents and Chemotherapy and American Journal of Tropical Medicine and Hygiene.

In The Last Decade

Daniel Eiras

13 papers receiving 370 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Efficacy, Immunogenicity, and Safety of the Bivalent Respiratory Syncytial Virus (RSV) Prefusion F Vaccine in Older Adults Over 2 RSV Seasons

2025 14 citations Edward E. Walsh, Daniel Eiras et al. Clinical Infectious Diseases profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Daniel Eiras United States	9	143	117	113	88	60	17	371
Monique R. Bidell United States	13	134 0.9×	157 1.3×	167 1.5×	75 0.9×	20 0.3×	26	607
Brent W. Gunderson United States	12	167 1.2×	185 1.6×	101 0.9×	51 0.6×	17 0.3×	15	455
Stephen Osmon United States	6	65 0.5×	32 0.3×	202 1.8×	33 0.4×	37 0.6×	10	568
Mary L. Townsend United States	12	46 0.3×	72 0.6×	159 1.4×	54 0.6×	20 0.3×	30	381
Piera Polidori Italy	10	77 0.5×	59 0.5×	44 0.4×	69 0.8×	25 0.4×	38	370
Hanine Mansour Lebanon	8	96 0.7×	55 0.5×	123 1.1×	108 1.2×	11 0.2×	21	387
Liesbet De Bus Belgium	14	67 0.5×	82 0.7×	188 1.7×	101 1.1×	30 0.5×	27	456
Roberto Andini Italy	14	423 3.0×	289 2.5×	300 2.7×	160 1.8×	40 0.7×	31	850
Winfried V. Kern Germany	13	45 0.3×	75 0.6×	179 1.6×	151 1.7×	23 0.4×	24	655
L. Farbman Israel	10	177 1.2×	113 1.0×	133 1.2×	51 0.6×	7 0.1×	12	417

Countries citing papers authored by Daniel Eiras

Since Specialization

Citations

This map shows the geographic impact of Daniel Eiras's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Eiras with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Eiras more than expected).

Fields of papers citing papers by Daniel Eiras

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Eiras. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Eiras. The network helps show where Daniel Eiras may publish in the future.

Co-authorship network of co-authors of Daniel Eiras

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Eiras. A scholar is included among the top collaborators of Daniel Eiras based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Eiras. Daniel Eiras is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Walsh, Edward E., Daniel Eiras, John Woodside, et al.. (2025). Efficacy, Immunogenicity, and Safety of the Bivalent Respiratory Syncytial Virus (RSV) Prefusion F Vaccine in Older Adults Over 2 RSV Seasons. Clinical Infectious Diseases. 81(6). e680–e689. 14 indexed citations breakdown →

Mikati, Tarek, Yasushi Fukushima, Daniel Eiras, et al.. (2025). P-605. Bivalent RSV Prefusion F-Based Subunit Vaccine Generates High and Durable Neutralizing Titers Across an Entire RSV Season among Older Adults. Open Forum Infectious Diseases. 12(Supplement_1).

Eiras, Daniel, Yasushi Fukushima, Qin Jiang, et al.. (2024). RSVpreF Vaccine Elicits a Robust and Durable Immune Response Among Adults Aged 60 Years and Older Across an Entire RSV Season. A2998–A2998.

Fukushima, Yasushi, José F. Cardona, Agnieszka Zareba, et al.. (2023). 1632. Bivalent RSV Prefusion F-Based Subunit Vaccine Generates High Neutralizing Titers in Older Adults. Open Forum Infectious Diseases. 10(Supplement_2).

Marc, Gonzalo Pérez, Edward E. Walsh, Elliot DeHaan, et al.. (2023). 1630. Clinical Profile of Acute Respiratory Illness (ARI) Events in the Phase 3 Trial The RSV Vaccine Efficacy Study iN Older Adults Immunized against RSV Disease (RENOIR). Open Forum Infectious Diseases. 10(Supplement_2).

Murray, Henry W., Daniel Eiras, Laura A. Kirkman, Raymond L. Chai, & Daniel Caplivski. (2020). Case Report: Mucosal Leishmaniasis in New York City. American Journal of Tropical Medicine and Hygiene. 102(6). 1319–1322. 5 indexed citations

Salsgiver, Elizabeth, Daniel Bernstein, Matthew S. Simon, et al.. (2018). Knowledge, Attitudes, and Practices Regarding Antimicrobial Use and Stewardship Among Prescribers at Acute-Care Hospitals. Infection Control and Hospital Epidemiology. 39(3). 316–322. 49 indexed citations

Guo, Yi, et al.. (2018). Nephrotoxicity Associated with Intravenous Polymyxin B Once- versus Twice-Daily Dosing Regimen. Antimicrobial Agents and Chemotherapy. 62(8). 16 indexed citations

Salsgiver, Elizabeth, Matthew S. Simon, William Greendyke, et al.. (2016). Understanding Barriers to Optimal Cleaning and Disinfection in Hospitals: A Knowledge, Attitudes, and Practices Survey of Environmental Services Workers. Infection Control and Hospital Epidemiology. 37(12). 1492–1495. 27 indexed citations

10.

Gomez‐Simmonds, Angela, Brian Nelson, Daniel Eiras, et al.. (2016). Combination Regimens for Treatment of Carbapenem-Resistant Klebsiella pneumoniae Bloodstream Infections. Antimicrobial Agents and Chemotherapy. 60(6). 3601–3607. 70 indexed citations

11.

Scipione, Marco R., et al.. (2016). Nephrotoxicity associated with intravenous (IV) polymyxin B (PMB) once versus twice daily dosing. Open Forum Infectious Diseases. 3(suppl_1). 1 indexed citations

12.

Eiras, Daniel, Laura A. Kirkman, & Henry W. Murray. (2015). Cutaneous Leishmaniasis: Current Treatment Practices in the USA for Returning Travelers. Current treatment options in infectious diseases. 7(1). 52–62. 44 indexed citations

13.

Bernstein, Daniel, Elizabeth Salsgiver, Matthew S. Simon, et al.. (2015). Qualitative and Quantitative Assessment of Daily Cleaning of High-Touch Environmental Surfaces in Hospital Patient Rooms. Open Forum Infectious Diseases. 2(suppl_1). 3 indexed citations

14.

Nelson, Brian, Daniel Eiras, Angela Gomez‐Simmonds, et al.. (2015). Clinical Outcomes Associated with Polymyxin B Dose in Patients with Bloodstream Infections Due to Carbapenem-Resistant Gram-Negative Rods. Antimicrobial Agents and Chemotherapy. 59(11). 7000–7006. 66 indexed citations

15.

Bernstein, Daniel, Elizabeth Salsgiver, Matthew S. Simon, et al.. (2015). Knowledge, Attitudes, and Practices of Environmental Service Workers Related to Environmental Cleaning and Healthcare-Associated Infections (HAI). Open Forum Infectious Diseases. 2(suppl_1). 2 indexed citations

16.

Zanichelli, Maria Aparecida, et al.. (2010). Impact of Epstein–Barr virus in the clinical evolution of patients with classical Hodgkin's lymphoma in Brazil. Hematological Oncology. 28(3). 137–141. 10 indexed citations

17.

Bourdi, Mohammed, Daniel Eiras, Michael P. Holt, et al.. (2007). Role of IL-6 in an IL-10 and IL-4 Double Knockout Mouse Model Uniquely Susceptible to Acetaminophen-Induced Liver Injury. Chemical Research in Toxicology. 20(2). 208–216. 64 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact